58 studies found for:    Open Studies | "Parathyroid Diseases"
Show Display Options
Rank Status Study
1 Recruiting Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas
Condition: Parathyroid Disease
Intervention: Drug: FACBC
2 Unknown  Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
Conditions: Osteoporosis;   Osteitis Deformans;   Parathyroid Diseases
Intervention:
3 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
4 Recruiting Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis
Condition: Hyperparathyroidism, Secondary
Interventions: Procedure: Subtotal Parathyroidectomy;   Procedure: Total Parathyroidectomy + 45 autografts;   Procedure: Total Parathyroidectomy + 90 autografts
5 Recruiting Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome
Conditions: Immune Defect;   22q11.2 Deletion Syndrome
Intervention:
6 Not yet recruiting Renal Osteodystrophy: An Individual Management Approach
Condition: Kidney Failure, Chronic
Interventions: Drug: Alendronate;   Drug: Teriparatide;   Drug: Cinacalcet
7 Recruiting Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas
Condition: Hyperparathyroidism
Intervention: Radiation: F18-choline  PET examination
8 Not yet recruiting Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism
Condition: Parathyroid Adenoma
Intervention:
9 Recruiting SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
Conditions: 22q11 Deletion Syndrome;   DiGeorge Syndrome;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Monosomy X;   Sex Chromosome Abnormalities;   Cri-du-Chat Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   1p36 Deletion Syndrome
Intervention:
10 Recruiting Single-arm Extension Study on the Safety of Cinacalcet Treatment in SHPT in Pediatric Subjects With CKD on Dialysis
Condition: Secondary Hyperparathyroidism, Chronic Kidney Disease
Intervention: Drug: Cinacalcet
11 Not yet recruiting Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients
Condition: Secondary Hyperparathyroidism
Intervention: Drug: Combination Cinacalcet with Vitamin D analogue
12 Not yet recruiting The Efficacy and Safety of Microwave Ablation in Hemodialysis Patients With Secondary Hyperparathyroidism in Early Stage
Conditions: Secondary Hyperparathyroidism;   Maintenance Hemodialysis
Interventions: Procedure: microwave ablation;   Drug: active vitamin D
13 Recruiting Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Conditions: Breast Cancer;   Prostate Cancer;   Bone Neoplasms;   Hypocalcemia;   Hyperparathyroidism, Secondary
Intervention: Drug: CTAP101 Capsules
14 Not yet recruiting Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
Condition: Hyperparathyroidism, Secondary
Interventions: Drug: standard care;   Drug: Optimal (I. iPTH control: Zemplar®,Mimpara®; phosphorous control: Renvela®, Phoslo®, Osvaren®, Foznol®,Maalox®; calcium control: calcium and vitamin D
15 Recruiting Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Condition: Primary Hyperparathyroidism
Interventions: Drug: Cinacalcet;   Procedure: parathyroid adenomectomy
16 Recruiting Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
Conditions: Chronic Renal Insufficiency;   Renal Osteodystrophy
Intervention:
17 Recruiting A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Condition: Chronic Kidney Disease, Secondary Hyperparathyroidism
Interventions: Drug: Cinacalcet HCl;   Dietary Supplement: Standard of Care
18 Recruiting Intra-operative Infra-red Fluorescent Imaging in Thyroid and Parathyroid Surgery
Conditions: Total Thyroidectomy;   Bilateral Neck Exploration for Primary Hyperparathyroidism
Intervention: Other: MB and fluorescent imaging
19 Not yet recruiting Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
20 Recruiting The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid
Condition: Hyperparathyroidism, Secondary
Intervention: Drug: calcium sensing receptor agonist

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years